Using specific inhibitors, we demonstrated that each of these cytokines, particularly IL‐6 and GRO‐α, modulates the invasive behaviour of tumour cells, whereas the mechanism of transendothelial migration is completely independent of GRO‐α/CXCR2 signalling. The gene discussed is CXCR2; the disease is neoplasm.